Mountain View, United States
DNAnexus, famously known as The Enterprise Platform for Precision Health, has established itself as a frontrunner in the field of bioinformatics and genomics since its inception in 2009. Focused on accelerating personalized treatment development, DNAnexus leverages 15 years of industry expertise to provide a cloud platform that not only centralizes multimodal omics data but also supports an array of informatics use cases.
Headquartered in the United States, DNAnexus caters to the Biotechnology, Computing, and Clean Energy sectors. Their platform fosters a secure, collaborative ecosystem that facilitates data enrichment, leading to actionable insights crucial for improving patient lives. The company garnered significant financial attention with a $200.00M late-stage venture capital investment on 1 March 2022 from key players like Foresite Capital, Innovatus Capital Partners, Northpond Ventures, Perceptive Advisors, and Blackstone, underscoring strong investor confidence in its scalable and impactful business model.
